InternetIntelligenz 2.0

kostenlos Pressemitteilungen einstellen | veröffentlichen | verteilen

Pressemitteilungen

 

Downstream Processing Market | Industrial Outlook & New Revenue Pockets

ID: 1703624

The global downstream processing market is poised to reach USD 22.03 Billion by 2021 from USD 10.32 Billion in 2016, at a CAGR of 16.4% from 2016 to 2021.


(IINews) - According to a new market research report "Downstream Processing Market by Technique (Separation, Concentration, Purification), Product (Chromatography Column & Resin, Filter, Single use), Application (Mab Production), End User (Contract Manufacturing Organization) - Global Forecast to 2021", published by MarketsandMarkets, the global market is poised to reach USD 22.03 Billion by 2021 from USD 10.32 Billion in 2016, at a CAGR of 16.4% from 2016 to 2021.

The growth in the Downstream Processing Market will majorly be driven by the increasing demand for biopharmaceuticals, as downstream processing steps play a significant role in providing pure and quality products. However, the high cost of instruments used in downstream processing is expected to restrain the growth of this market. On the other hand, patent expiration of blockbuster biopharmaceutical products represents significant growth opportunities for the key players in the Downstream Processing Market.

Don’t miss the opportunities in global Downstream Processing Market. Speak to our Analyst for more detailed Information: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=73180930

The global Downstream Processing Market is broadly segmented on the basis of technique, product, application, end user, and region. On the basis of technique, the market is segmented into purification, solid-liquid separation, and clarification/concentration.

Browse and in-depth TOC on "Downstream Processing Market"
68 - Tables
40 - Figures
139 - Pages

Request Sample Report (at) https://www.marketsandmarkets.com/requestsampleNew.asp?id=73180930

In 2016, the purification segment accounted for the largest share of the market. This largest share and the high growth is attributed to the need for highly pure biopharmaceutical products to meet the regulatory standards, as downstream purification plays a significant role in enhancing the purity and quality of products aiding the growth of the purification market.





On the basis of product, the market is broadly classified into chromatography columns and resins, filters, membrane adsorbers, single-use products, and other products (consumables and accessories). In 2016, the chromatography columns and resins segment accounted for the largest share of the Downstream Processing Market.

Columns and resins are the most important component of a chromatography system and are extensively used in the separation, recovery, and purification of components of a bioactive sample. The constant need for newer and different types of columns and resins is likely to fuel market growth.

North America (comprising the U.S. and Canada) is expected to account for the largest share of the global Downstream Processing Market in 2016, followed by Europe. North America is the world''s largest pharmaceutical market and a leader in biopharmaceutical research. Rising quality requirements have emphasized the need for advanced bioproduction technology in this region. Asia-Pacific is expected to grow at the highest CAGR during the forecast period. The Asia-Pacific Downstream Processing Market, particularly in China, Japan, India, and South Korea, is expected to witness high growth. In addition, growth in these markets will be fueled by significant investments by key market players, increasing government support, developing R&D infrastructure, and growing expertise & academic excellence.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=73180930

The Downstream Processing Market is dominated by established players such as Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.S.), Sartorius Stedim Biotech S.A. (France), Merck Millipore (Germany), and Danaher Corporation (U.S.).


Themen in diesem Fachartikel:


Unternehmensinformation / Kurzprofil:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies'' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets''s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.



Leseranfragen:

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com



PresseKontakt / Agentur:

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com



drucken  als PDF  an Freund senden  Fujifilm erwirbt großen Produktionsstandort für Biologika von Biogen, um Wachstum seines Bio-CDMO-Geschäfts zu beschleunigen
Schwächen bei der Darmkrebsvorsorge: Wie ein moderner Enzym-Biomarker
die Versorgungslücke schließen kann
Bereitgestellt von Benutzer: dheerajshaha67
Datum: 12.03.2019 - 10:13 Uhr
Sprache: Deutsch
News-ID 1703624
Anzahl Zeichen: 0

Kontakt-Informationen:
Ansprechpartner: Dheeraj Shaha
Stadt:

Northbrook


Telefon: 1886006441

Kategorie:

Biotechnologie


Anmerkungen:


Dieser Fachartikel wurde bisher 152 mal aufgerufen.


Der Fachartikel mit dem Titel:
"Downstream Processing Market | Industrial Outlook & New Revenue Pockets
"
steht unter der journalistisch-redaktionellen Verantwortung von

MnM (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von MnM



 

Wer ist Online

Alle Mitglieder: 50.218
Registriert Heute: 0
Registriert Gestern: 0
Mitglied(er) online: 0
Gäste Online: 401


Bitte registrieren Sie sich hier. Als angemeldeter Benutzer nutzen Sie den vollen Funktionsumfang dieser Seite.